Elanco Animal Health has unveiled plans for its new global headquarters on the site of the former GM Stamping Plant.

The recently announced global headquarters will consolidate Elanco's operations from around the world to the westside of Indianapolis.

Elanco was spun off from the Indianapolis drugmaker Eli Lilly and Co. It makes antibiotics and feed additives for livestock and flea and heartworm treatments for pets.

Indiana-based Elanco Animal Health is set to become the second largest animal health company in the world. The company announced the $7.6 billion agreement with Bayer Tuesday.

The company expects to complete the IPO by the end of this year and divest its remaining stake in the business possibly by next year.

If Eli Lilly and Co. officials were to sell or spin off Elanco Animal Health, there's no guarantee the operation would remain in the city.